NCT06487546View on ClinicalTrials.gov

Repletion of Ergothioneine in Patients With Kidney Failure

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

October 1, 2027

Conditions

Esrd

Interventions

DIETARY_SUPPLEMENT

Ergothioneine

This is a 1-arm study in which participants will take ergothioneine daily with dose range of 5 mg to 25 mg daily. Blood levels of ergothioneine will be monitored while taking daily ergothioneine and after ergothioneine is stopped.

All Listed Sponsors

lead

Stanford University

OTHER

NCT06487546 - Repletion of Ergothioneine in Patients With Kidney Failure | Biotech Hunter | Biotech Hunter